HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanjiv S Gambhir Selected Research

Breast Neoplasms (Breast Cancer)

1/2020Two Patient Studies of a Companion Diagnostic Immuno-Positron Emission Tomography (PET) Tracer for Measuring Human CA6 Expression in Cancer for Antibody Drug Conjugate (ADC) Therapy.
6/2019Photoacoustic clinical imaging.
1/2019[18F]-SuPAR: A Radiofluorinated Probe for Noninvasive Imaging of DNA Damage-Dependent Poly(ADP-ribose) Polymerase Activity.
11/2018Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents.
9/2013A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide.
3/2013Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.
10/2012Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.
7/2012In vivo targeting of HER2-positive tumor using 2-helix affibody molecules.
2/2012Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model.
1/2011GLUT 5 is not over-expressed in breast cancer cells and patient breast cancer tissues.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sanjiv S Gambhir Research Topics

Disease

185Neoplasms (Cancer)
05/2022 - 05/2002
21Prostatic Neoplasms (Prostate Cancer)
10/2020 - 03/2002
17Glioblastoma (Glioblastoma Multiforme)
01/2022 - 12/2006
17Neoplasm Metastasis (Metastasis)
01/2020 - 08/2003
14Breast Neoplasms (Breast Cancer)
01/2020 - 06/2004
12Glioma (Gliomas)
01/2022 - 09/2002
9Melanoma (Melanoma, Malignant)
01/2014 - 03/2002
8Inflammation (Inflammations)
01/2019 - 04/2004
7Brain Neoplasms (Brain Tumor)
11/2020 - 07/2005
7Carcinoma (Carcinomatosis)
12/2019 - 12/2009
7Hypoxia (Hypoxemia)
01/2015 - 08/2003
6Lymphoma (Lymphomas)
05/2022 - 06/2012
6Infections
01/2020 - 05/2002
6Lung Neoplasms (Lung Cancer)
01/2020 - 06/2002
6Myocardial Ischemia (Ischemic Heart Diseases)
10/2013 - 01/2003
5Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 02/2007
5Hepatocellular Carcinoma (Hepatoma)
08/2021 - 06/2005
5Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 09/2008
5Pancreatic Neoplasms (Pancreatic Cancer)
07/2018 - 06/2009
5Circulating Neoplastic Cells
01/2017 - 09/2011
5Herpes Simplex
04/2006 - 01/2003
4Adenocarcinoma
11/2020 - 03/2010
4Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2020 - 01/2013
4Myocardial Infarction
01/2020 - 05/2011
4Colonic Neoplasms (Colon Cancer)
12/2016 - 10/2009
4Ischemia
09/2010 - 02/2008
3Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2021 - 12/2009
3Pancreatitis
11/2020 - 01/2018
3Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 08/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 01/2013

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2002
24Thymidine KinaseIBA
10/2021 - 05/2002
22Biomarkers (Surrogate Marker)IBA
12/2021 - 08/2008
21IntegrinsIBA
10/2019 - 10/2005
13Pharmaceutical PreparationsIBA
01/2021 - 03/2004
12Glucose (Dextrose)FDA LinkGeneric
01/2021 - 03/2002
12LigandsIBA
01/2019 - 08/2003
12Peptides (Polypeptides)IBA
01/2018 - 04/2006
11Firefly LuciferasesIBA
05/2022 - 03/2002
11Biological ProductsIBA
01/2022 - 02/2007
11Contrast MediaIBA
11/2020 - 02/2008
11AntigensIBA
06/2020 - 02/2003
10arginyl-glycyl-aspartic acidIBA
11/2014 - 10/2005
9Ganciclovir (Cytovene)FDA LinkGeneric
11/2020 - 05/2002
9Molecular Probes (Molecular Probe)IBA
12/2016 - 04/2004
9Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2016 - 03/2005
8LuciferasesIBA
10/2021 - 10/2005
8AndrogensIBA
01/2020 - 03/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014 - 08/2003
7ErbB Receptors (EGF Receptor)IBA
11/2021 - 08/2003
79-(4-fluoro-3-hydroxymethylbutyl)guanineIBA
11/2020 - 01/2003
7AntibodiesIBA
01/2019 - 12/2003
7Tumor Biomarkers (Tumor Markers)IBA
01/2019 - 08/2008
7tumor-associated transplantation antigen (TSTA)IBA
05/2012 - 03/2002
6Indicators and Reagents (Reagents)IBA
10/2021 - 10/2005
6GuanineIBA
11/2020 - 01/2003
6Glutamic Acid (Glutamate)FDA Link
10/2020 - 10/2012
6ProdrugsIBA
03/2020 - 05/2002
6Radioisotopes (Radionuclides)IBA
12/2015 - 12/2003
6Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2013 - 11/2006
6Renilla LuciferasesIBA
09/2012 - 10/2006
61,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
07/2012 - 10/2005
6Integrin alphaVbeta3IBA
01/2008 - 10/2005
5GoldIBA
12/2021 - 11/2012
5RadiopharmaceuticalsIBA
10/2020 - 12/2006
5Cystine-Knot MiniproteinsIBA
10/2019 - 03/2010
5Prostate-Specific Antigen (Semenogelase)IBA
11/2005 - 08/2002
4Therapeutic UsesIBA
12/2021 - 04/2009
4SurvivinIBA
10/2021 - 11/2008
4Nucleic AcidsIBA
03/2020 - 01/2018
4EnzymesIBA
03/2020 - 09/2002
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 03/2011
4Cystine (L-Cystine)IBA
10/2019 - 02/2012
4MicroRNAs (MicroRNA)IBA
10/2019 - 01/2018
4Androgen Receptors (Androgen Receptor)IBA
09/2015 - 08/2003
4Immunoglobulin FragmentsIBA
07/2015 - 12/2003
4penciclovir (Denavir)FDA Link
02/2014 - 09/2002
3Chimeric Antigen ReceptorsIBA
11/2020 - 01/2020
34-(3-fluoropropyl)glutamic acidIBA
08/2020 - 02/2018
3Cell Surface ReceptorsIBA
01/2020 - 02/2012
3AcidsIBA
01/2018 - 12/2006
3withaferin AIBA
09/2017 - 01/2016
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2017 - 08/2010
3Messenger RNA (mRNA)IBA
01/2017 - 01/2002
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2013 - 08/2003

Therapy/Procedure

75Therapeutics
12/2021 - 06/2002
12Immunotherapy
05/2022 - 01/2014
11Microbubbles
01/2020 - 02/2008
9Drug Therapy (Chemotherapy)
01/2020 - 02/2006
6Intravenous Administration
03/2014 - 01/2006
5Precision Medicine
01/2021 - 09/2011
5Radiotherapy
01/2020 - 04/2010
5Ligation
01/2020 - 08/2004
4Endoscopes
10/2018 - 08/2011
4Transplantation
09/2012 - 01/2009
4Intravenous Injections
04/2012 - 01/2006
3Cell Transplantation
01/2022 - 01/2016
3Castration
01/2020 - 08/2003
3Aftercare (After-Treatment)
01/2018 - 03/2011
3Lasers (Laser)
01/2013 - 02/2008